9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 104 filers reported holding 9 METERS BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,795,000 | -25.0% | 13,000,000 | -9.1% | 0.01% | -22.2% |
| Q2 2022 | $3,728,000 | -58.5% | 14,295,627 | -4.7% | 0.01% | -47.1% |
| Q1 2022 | $8,990,000 | -38.8% | 15,000,000 | 0.0% | 0.02% | -34.6% |
| Q4 2021 | $14,681,000 | -24.7% | 15,000,000 | 0.0% | 0.03% | -31.6% |
| Q3 2021 | $19,500,000 | +18.2% | 15,000,000 | 0.0% | 0.04% | +18.8% |
| Q2 2021 | $16,500,000 | -3.7% | 15,000,000 | +2.4% | 0.03% | -8.6% |
| Q1 2021 | $17,141,000 | +53.5% | 14,650,000 | +12.7% | 0.04% | +45.8% |
| Q4 2020 | $11,167,000 | – | 13,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,328,306 | $4,236,000 | 3.29% |
| Ghost Tree Capital, LLC | 3,250,000 | $3,181,000 | 1.14% |
| ODonnell Financial Services, LLC | 852,628 | $629,000 | 0.29% |
| Orbimed Advisors | 10,275,887 | $10,057,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 495,783 | $485,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $14,681,000 | 0.03% |
| Prentice Wealth Management LLC | 35,000 | $34,000 | 0.02% |
| XTX Topco Ltd | 27,147 | $27,000 | 0.02% |
| Ascent Wealth Partners, LLC | 85,224 | $83,000 | 0.02% |
| Virtu Financial LLC | 110,465 | $108,000 | 0.01% |